Article
Predicted Risk of Ventricular Arrhythmias in a Genome-First Population With Genetic Risk for Arrhythmogenic Right Ventricular Cardiomyopathy.
Circulation. Arrhythmia and electrophysiology - 1 Mar 2025
Carruth Eric D, Murray Brittney, Tichnell Crystal, Young Katelyn, Calkins Hugh, James Cynthia A, Haggerty Christopher M
Abstract excerpt
BACKGROUND: Population genomic screening for desmosome variants associated with arrhythmogenic right ventricular cardiomyopathy (ARVC) may facilitate early disease detection and protective intervention. The validated ARVC risk calculator offers a novel means to risk stratify individuals with diagnosed ARVC, but predicted risk in the context of genomic screening identification has not been explored. METHODS:...
Topics
Join the communities discussing this publication.
